But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Pfizer discontinues danuglipron after liver injury in trial patient Lilly and Novo Nordisk shares rise after ... of experimental weight-loss pill danuglipron after a trial patient experienced ...

The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

It's little secret that America has a weight problem. For decades, Americans have embraced and abandoned countless ...

Trump's latest executive order aims to reduce prescription drug costs through a series of measures, including changes to the ...

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like Ozempic.

April 14 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its ...

Kennedy Jr. to work with lawmakers to address a long-standing issue called the “pill penalty” in the negotiation ... setting four years earlier than large molecules such as biologics following ...

Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...